Terazosin Capsule
Product Images NDC 72162-2183

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 72162-2183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622183)

Label for Terazosin Capsules USP, 5 mg strength, containing 1000 capsules. The label indicates the active ingredient as Terazosin Hydrochloride equivalent to Terazosin 5 mg per capsule. It is relabeled by Bryant Ranch Prepack and manufactured by Jubilant Cadista Pharmaceuticals Inc. Storage instructions are to keep at 20-25°C (68-77°F) in a tight, light-resistant container.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin Hydrochloride, showing its molecular framework including aromatic rings, nitrogen atoms, and ether groups.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

This image contains two graphs comparing placebo and Terazosin treatment over 3 months. The left graph shows mean change in total symptom score from baseline with Terazosin showing a decrease over time compared to placebo. The right graph shows mean increase in peak flow rate (mL/sec) from baseline, with Terazosin demonstrating a greater increase compared to placebo across 3 months.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line graph showing mean change from baseline over a span of 30 months. The y-axis represents mean change values while the x-axis represents months. Data points are plotted with markers connected by a line, and stars indicate statistically significant changes at several time points.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

A line graph depicting mean change from baseline over 30 months, with data points and error bars plotted at monthly intervals. The y-axis measures mean change from baseline in an unspecified measure (N=15 per group), and several data points are indicated as statistically significant with asterisks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.